0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Montelukast Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-31Z71
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Montelukast Sodium Market Insights and Forecast to 2028
BUY CHAPTERS

Montelukast Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-31Z71
Report
August 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Montelukast Sodium- Market Size

The global market for Montelukast Sodium was estimated to be worth US$ 438 million in 2024 and is forecast to a readjusted size of US$ 1019 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.

Montelukast Sodium- Market

Montelukast Sodium- Market

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
This report aims to provide a comprehensive presentation of the global market for Montelukast Sodium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Montelukast Sodium by region & country, by Type, and by Application.
The Montelukast Sodium market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast Sodium.
Market Segmentation

Scope of Montelukast Sodium- Market Report

Report Metric Details
Report Name Montelukast Sodium- Market
Forecasted market size in 2031 US$ 1019 million
CAGR 13.0%
Forecasted years 2025 - 2031
Segment by Type
  • Montelukast Sodium Amorphous
  • Montelukast Sodium Crystalline
Segment by Application
  • Tablets
  • Chewable Tablet
  • Oral Solution
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Vamsi Labs, Adley Group, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Montelukast Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Montelukast Sodium in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Montelukast Sodium- Market size in 2031?

Ans: The Montelukast Sodium- Market size in 2031 will be US$ 1019 million.

What is the Morepen Laboratories share in Montelukast Sodium- Market?

Ans: Morepen Laboratories is the globe sales leader, holding 22% sales share in global.

Who are the main players in the Montelukast Sodium- Market report?

Ans: The main players in the Montelukast Sodium- Market are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Vamsi Labs, Adley Group, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical

What are the Application segmentation covered in the Montelukast Sodium- Market report?

Ans: The Applications covered in the Montelukast Sodium- Market report are Tablets, Chewable Tablet, Oral Solution

What are the Type segmentation covered in the Montelukast Sodium- Market report?

Ans: The Types covered in the Montelukast Sodium- Market report are Montelukast Sodium Amorphous, Montelukast Sodium Crystalline

1 Market Overview
1.1 Montelukast Sodium Product Introduction
1.2 Global Montelukast Sodium Market Size Forecast
1.2.1 Global Montelukast Sodium Sales Value (2020-2031)
1.2.2 Global Montelukast Sodium Sales Volume (2020-2031)
1.2.3 Global Montelukast Sodium Sales Price (2020-2031)
1.3 Montelukast Sodium Market Trends & Drivers
1.3.1 Montelukast Sodium Industry Trends
1.3.2 Montelukast Sodium Market Drivers & Opportunity
1.3.3 Montelukast Sodium Market Challenges
1.3.4 Montelukast Sodium Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Montelukast Sodium Players Revenue Ranking (2024)
2.2 Global Montelukast Sodium Revenue by Company (2020-2025)
2.3 Global Montelukast Sodium Players Sales Volume Ranking (2024)
2.4 Global Montelukast Sodium Sales Volume by Company Players (2020-2025)
2.5 Global Montelukast Sodium Average Price by Company (2020-2025)
2.6 Key Manufacturers Montelukast Sodium Manufacturing Base and Headquarters
2.7 Key Manufacturers Montelukast Sodium Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Montelukast Sodium
2.9 Montelukast Sodium Market Competitive Analysis
2.9.1 Montelukast Sodium Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Montelukast Sodium Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Montelukast Sodium Amorphous
3.1.2 Montelukast Sodium Crystalline
3.2 Global Montelukast Sodium Sales Value by Type
3.2.1 Global Montelukast Sodium Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Montelukast Sodium Sales Value, by Type (2020-2031)
3.2.3 Global Montelukast Sodium Sales Value, by Type (%) (2020-2031)
3.3 Global Montelukast Sodium Sales Volume by Type
3.3.1 Global Montelukast Sodium Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Montelukast Sodium Sales Volume, by Type (2020-2031)
3.3.3 Global Montelukast Sodium Sales Volume, by Type (%) (2020-2031)
3.4 Global Montelukast Sodium Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Chewable Tablet
4.1.3 Oral Solution
4.2 Global Montelukast Sodium Sales Value by Application
4.2.1 Global Montelukast Sodium Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Montelukast Sodium Sales Value, by Application (2020-2031)
4.2.3 Global Montelukast Sodium Sales Value, by Application (%) (2020-2031)
4.3 Global Montelukast Sodium Sales Volume by Application
4.3.1 Global Montelukast Sodium Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Montelukast Sodium Sales Volume, by Application (2020-2031)
4.3.3 Global Montelukast Sodium Sales Volume, by Application (%) (2020-2031)
4.4 Global Montelukast Sodium Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Montelukast Sodium Sales Value by Region
5.1.1 Global Montelukast Sodium Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Montelukast Sodium Sales Value by Region (2020-2025)
5.1.3 Global Montelukast Sodium Sales Value by Region (2026-2031)
5.1.4 Global Montelukast Sodium Sales Value by Region (%), (2020-2031)
5.2 Global Montelukast Sodium Sales Volume by Region
5.2.1 Global Montelukast Sodium Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Montelukast Sodium Sales Volume by Region (2020-2025)
5.2.3 Global Montelukast Sodium Sales Volume by Region (2026-2031)
5.2.4 Global Montelukast Sodium Sales Volume by Region (%), (2020-2031)
5.3 Global Montelukast Sodium Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Montelukast Sodium Sales Value, 2020-2031
5.4.2 North America Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Montelukast Sodium Sales Value, 2020-2031
5.5.2 Europe Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Montelukast Sodium Sales Value, 2020-2031
5.6.2 Asia Pacific Montelukast Sodium Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Montelukast Sodium Sales Value, 2020-2031
5.7.2 South America Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Montelukast Sodium Sales Value, 2020-2031
5.8.2 Middle East & Africa Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Montelukast Sodium Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Montelukast Sodium Sales Value
6.2.1 Key Countries/Regions Montelukast Sodium Sales Value, 2020-2031
6.2.2 Key Countries/Regions Montelukast Sodium Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Montelukast Sodium Sales Value, 2020-2031
6.3.2 United States Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Montelukast Sodium Sales Value, 2020-2031
6.4.2 Europe Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Montelukast Sodium Sales Value, 2020-2031
6.5.2 China Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.5.3 China Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Montelukast Sodium Sales Value, 2020-2031
6.6.2 Japan Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Montelukast Sodium Sales Value, 2020-2031
6.7.2 South Korea Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Montelukast Sodium Sales Value, 2020-2031
6.8.2 Southeast Asia Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Montelukast Sodium Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Montelukast Sodium Sales Value, 2020-2031
6.9.2 India Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
6.9.3 India Montelukast Sodium Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Morepen Laboratories
7.1.1 Morepen Laboratories Company Information
7.1.2 Morepen Laboratories Introduction and Business Overview
7.1.3 Morepen Laboratories Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Morepen Laboratories Montelukast Sodium Product Offerings
7.1.5 Morepen Laboratories Recent Development
7.2 Mylan
7.2.1 Mylan Company Information
7.2.2 Mylan Introduction and Business Overview
7.2.3 Mylan Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mylan Montelukast Sodium Product Offerings
7.2.5 Mylan Recent Development
7.3 TAPI
7.3.1 TAPI Company Information
7.3.2 TAPI Introduction and Business Overview
7.3.3 TAPI Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 TAPI Montelukast Sodium Product Offerings
7.3.5 TAPI Recent Development
7.4 MSN Laboratories
7.4.1 MSN Laboratories Company Information
7.4.2 MSN Laboratories Introduction and Business Overview
7.4.3 MSN Laboratories Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 MSN Laboratories Montelukast Sodium Product Offerings
7.4.5 MSN Laboratories Recent Development
7.5 Ultratech India
7.5.1 Ultratech India Company Information
7.5.2 Ultratech India Introduction and Business Overview
7.5.3 Ultratech India Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Ultratech India Montelukast Sodium Product Offerings
7.5.5 Ultratech India Recent Development
7.6 Aurobindo Pharma
7.6.1 Aurobindo Pharma Company Information
7.6.2 Aurobindo Pharma Introduction and Business Overview
7.6.3 Aurobindo Pharma Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Aurobindo Pharma Montelukast Sodium Product Offerings
7.6.5 Aurobindo Pharma Recent Development
7.7 Hetero Labs
7.7.1 Hetero Labs Company Information
7.7.2 Hetero Labs Introduction and Business Overview
7.7.3 Hetero Labs Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hetero Labs Montelukast Sodium Product Offerings
7.7.5 Hetero Labs Recent Development
7.8 Unimark Remedies
7.8.1 Unimark Remedies Company Information
7.8.2 Unimark Remedies Introduction and Business Overview
7.8.3 Unimark Remedies Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Unimark Remedies Montelukast Sodium Product Offerings
7.8.5 Unimark Remedies Recent Development
7.9 Jubilant Cadista
7.9.1 Jubilant Cadista Company Information
7.9.2 Jubilant Cadista Introduction and Business Overview
7.9.3 Jubilant Cadista Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Jubilant Cadista Montelukast Sodium Product Offerings
7.9.5 Jubilant Cadista Recent Development
7.10 Aamorb Pharmaceuticals
7.10.1 Aamorb Pharmaceuticals Company Information
7.10.2 Aamorb Pharmaceuticals Introduction and Business Overview
7.10.3 Aamorb Pharmaceuticals Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Aamorb Pharmaceuticals Montelukast Sodium Product Offerings
7.10.5 Aamorb Pharmaceuticals Recent Development
7.11 Sudarshan Group
7.11.1 Sudarshan Group Company Information
7.11.2 Sudarshan Group Introduction and Business Overview
7.11.3 Sudarshan Group Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Sudarshan Group Montelukast Sodium Product Offerings
7.11.5 Sudarshan Group Recent Development
7.12 Ortin Laboratories
7.12.1 Ortin Laboratories Company Information
7.12.2 Ortin Laboratories Introduction and Business Overview
7.12.3 Ortin Laboratories Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Ortin Laboratories Montelukast Sodium Product Offerings
7.12.5 Ortin Laboratories Recent Development
7.13 Vamsi Labs
7.13.1 Vamsi Labs Company Information
7.13.2 Vamsi Labs Introduction and Business Overview
7.13.3 Vamsi Labs Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Vamsi Labs Montelukast Sodium Product Offerings
7.13.5 Vamsi Labs Recent Development
7.14 Adley Group
7.14.1 Adley Group Company Information
7.14.2 Adley Group Introduction and Business Overview
7.14.3 Adley Group Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Adley Group Montelukast Sodium Product Offerings
7.14.5 Adley Group Recent Development
7.15 Medopharm
7.15.1 Medopharm Company Information
7.15.2 Medopharm Introduction and Business Overview
7.15.3 Medopharm Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Medopharm Montelukast Sodium Product Offerings
7.15.5 Medopharm Recent Development
7.16 Hengyuan Pharmaceutical
7.16.1 Hengyuan Pharmaceutical Company Information
7.16.2 Hengyuan Pharmaceutical Introduction and Business Overview
7.16.3 Hengyuan Pharmaceutical Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Hengyuan Pharmaceutical Montelukast Sodium Product Offerings
7.16.5 Hengyuan Pharmaceutical Recent Development
7.17 Arromax Pharmaceutical Technology
7.17.1 Arromax Pharmaceutical Technology Company Information
7.17.2 Arromax Pharmaceutical Technology Introduction and Business Overview
7.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Arromax Pharmaceutical Technology Montelukast Sodium Product Offerings
7.17.5 Arromax Pharmaceutical Technology Recent Development
7.18 Lihe Wuhan New Chemical Materials
7.18.1 Lihe Wuhan New Chemical Materials Company Information
7.18.2 Lihe Wuhan New Chemical Materials Introduction and Business Overview
7.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Offerings
7.18.5 Lihe Wuhan New Chemical Materials Recent Development
7.19 Shanghai Huachu Chemical
7.19.1 Shanghai Huachu Chemical Company Information
7.19.2 Shanghai Huachu Chemical Introduction and Business Overview
7.19.3 Shanghai Huachu Chemical Montelukast Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Shanghai Huachu Chemical Montelukast Sodium Product Offerings
7.19.5 Shanghai Huachu Chemical Recent Development
8 Industry Chain Analysis
8.1 Montelukast Sodium Industrial Chain
8.2 Montelukast Sodium Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Montelukast Sodium Sales Model
8.5.2 Sales Channel
8.5.3 Montelukast Sodium Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Montelukast Sodium Market Trends
 Table 2. Montelukast Sodium Market Drivers & Opportunity
 Table 3. Montelukast Sodium Market Challenges
 Table 4. Montelukast Sodium Market Restraints
 Table 5. Global Montelukast Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Montelukast Sodium Revenue Market Share by Company (2020-2025)
 Table 7. Global Montelukast Sodium Sales Volume by Company (2020-2025) & (Kg)
 Table 8. Global Montelukast Sodium Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Montelukast Sodium Price by Company (2020-2025) & (USD/Kg)
 Table 10. Key Manufacturers Montelukast Sodium Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Montelukast Sodium Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Montelukast Sodium
 Table 13. Global Montelukast Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Montelukast Sodium Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Montelukast Sodium Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Montelukast Sodium Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Montelukast Sodium Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Montelukast Sodium Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Montelukast Sodium Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
 Table 22. Global Montelukast Sodium Sales Volume by Type (2020-2025) & (Kg)
 Table 23. Global Montelukast Sodium Sales Volume by Type (2026-2031) & (Kg)
 Table 24. Global Montelukast Sodium Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Montelukast Sodium Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Montelukast Sodium Price by Type (2020-2025) & (USD/Kg)
 Table 27. Global Montelukast Sodium Price by Type (2026-2031) & (USD/Kg)
 Table 28. Global Montelukast Sodium Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Montelukast Sodium Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Montelukast Sodium Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Montelukast Sodium Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Montelukast Sodium Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Montelukast Sodium Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
 Table 34. Global Montelukast Sodium Sales Volume by Application (2020-2025) & (Kg)
 Table 35. Global Montelukast Sodium Sales Volume by Application (2026-2031) & (Kg)
 Table 36. Global Montelukast Sodium Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Montelukast Sodium Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Montelukast Sodium Price by Application (2020-2025) & (USD/Kg)
 Table 39. Global Montelukast Sodium Price by Application (2026-2031) & (USD/Kg)
 Table 40. Global Montelukast Sodium Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Montelukast Sodium Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Montelukast Sodium Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Montelukast Sodium Sales Value by Region (2020-2025) & (%)
 Table 44. Global Montelukast Sodium Sales Value by Region (2026-2031) & (%)
 Table 45. Global Montelukast Sodium Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
 Table 46. Global Montelukast Sodium Sales Volume by Region (2020-2025) & (Kg)
 Table 47. Global Montelukast Sodium Sales Volume by Region (2026-2031) & (Kg)
 Table 48. Global Montelukast Sodium Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Montelukast Sodium Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Montelukast Sodium Average Price by Region (2020-2025) & (USD/Kg)
 Table 51. Global Montelukast Sodium Average Price by Region (2026-2031) & (USD/Kg)
 Table 52. Key Countries/Regions Montelukast Sodium Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Montelukast Sodium Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Montelukast Sodium Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Montelukast Sodium Sales Volume, (2020-2025) & (Kg)
 Table 56. Key Countries/Regions Montelukast Sodium Sales Volume, (2026-2031) & (Kg)
 Table 57. Morepen Laboratories Company Information
 Table 58. Morepen Laboratories Introduction and Business Overview
 Table 59. Morepen Laboratories Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 60. Morepen Laboratories Montelukast Sodium Product Offerings
 Table 61. Morepen Laboratories Recent Development
 Table 62. Mylan Company Information
 Table 63. Mylan Introduction and Business Overview
 Table 64. Mylan Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 65. Mylan Montelukast Sodium Product Offerings
 Table 66. Mylan Recent Development
 Table 67. TAPI Company Information
 Table 68. TAPI Introduction and Business Overview
 Table 69. TAPI Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 70. TAPI Montelukast Sodium Product Offerings
 Table 71. TAPI Recent Development
 Table 72. MSN Laboratories Company Information
 Table 73. MSN Laboratories Introduction and Business Overview
 Table 74. MSN Laboratories Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 75. MSN Laboratories Montelukast Sodium Product Offerings
 Table 76. MSN Laboratories Recent Development
 Table 77. Ultratech India Company Information
 Table 78. Ultratech India Introduction and Business Overview
 Table 79. Ultratech India Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 80. Ultratech India Montelukast Sodium Product Offerings
 Table 81. Ultratech India Recent Development
 Table 82. Aurobindo Pharma Company Information
 Table 83. Aurobindo Pharma Introduction and Business Overview
 Table 84. Aurobindo Pharma Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 85. Aurobindo Pharma Montelukast Sodium Product Offerings
 Table 86. Aurobindo Pharma Recent Development
 Table 87. Hetero Labs Company Information
 Table 88. Hetero Labs Introduction and Business Overview
 Table 89. Hetero Labs Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 90. Hetero Labs Montelukast Sodium Product Offerings
 Table 91. Hetero Labs Recent Development
 Table 92. Unimark Remedies Company Information
 Table 93. Unimark Remedies Introduction and Business Overview
 Table 94. Unimark Remedies Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 95. Unimark Remedies Montelukast Sodium Product Offerings
 Table 96. Unimark Remedies Recent Development
 Table 97. Jubilant Cadista Company Information
 Table 98. Jubilant Cadista Introduction and Business Overview
 Table 99. Jubilant Cadista Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 100. Jubilant Cadista Montelukast Sodium Product Offerings
 Table 101. Jubilant Cadista Recent Development
 Table 102. Aamorb Pharmaceuticals Company Information
 Table 103. Aamorb Pharmaceuticals Introduction and Business Overview
 Table 104. Aamorb Pharmaceuticals Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 105. Aamorb Pharmaceuticals Montelukast Sodium Product Offerings
 Table 106. Aamorb Pharmaceuticals Recent Development
 Table 107. Sudarshan Group Company Information
 Table 108. Sudarshan Group Introduction and Business Overview
 Table 109. Sudarshan Group Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 110. Sudarshan Group Montelukast Sodium Product Offerings
 Table 111. Sudarshan Group Recent Development
 Table 112. Ortin Laboratories Company Information
 Table 113. Ortin Laboratories Introduction and Business Overview
 Table 114. Ortin Laboratories Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 115. Ortin Laboratories Montelukast Sodium Product Offerings
 Table 116. Ortin Laboratories Recent Development
 Table 117. Vamsi Labs Company Information
 Table 118. Vamsi Labs Introduction and Business Overview
 Table 119. Vamsi Labs Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 120. Vamsi Labs Montelukast Sodium Product Offerings
 Table 121. Vamsi Labs Recent Development
 Table 122. Adley Group Company Information
 Table 123. Adley Group Introduction and Business Overview
 Table 124. Adley Group Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 125. Adley Group Montelukast Sodium Product Offerings
 Table 126. Adley Group Recent Development
 Table 127. Medopharm Company Information
 Table 128. Medopharm Introduction and Business Overview
 Table 129. Medopharm Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 130. Medopharm Montelukast Sodium Product Offerings
 Table 131. Medopharm Recent Development
 Table 132. Hengyuan Pharmaceutical Company Information
 Table 133. Hengyuan Pharmaceutical Introduction and Business Overview
 Table 134. Hengyuan Pharmaceutical Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 135. Hengyuan Pharmaceutical Montelukast Sodium Product Offerings
 Table 136. Hengyuan Pharmaceutical Recent Development
 Table 137. Arromax Pharmaceutical Technology Company Information
 Table 138. Arromax Pharmaceutical Technology Introduction and Business Overview
 Table 139. Arromax Pharmaceutical Technology Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 140. Arromax Pharmaceutical Technology Montelukast Sodium Product Offerings
 Table 141. Arromax Pharmaceutical Technology Recent Development
 Table 142. Lihe Wuhan New Chemical Materials Company Information
 Table 143. Lihe Wuhan New Chemical Materials Introduction and Business Overview
 Table 144. Lihe Wuhan New Chemical Materials Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 145. Lihe Wuhan New Chemical Materials Montelukast Sodium Product Offerings
 Table 146. Lihe Wuhan New Chemical Materials Recent Development
 Table 147. Shanghai Huachu Chemical Company Information
 Table 148. Shanghai Huachu Chemical Introduction and Business Overview
 Table 149. Shanghai Huachu Chemical Montelukast Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 150. Shanghai Huachu Chemical Montelukast Sodium Product Offerings
 Table 151. Shanghai Huachu Chemical Recent Development
 Table 152. Key Raw Materials Lists
 Table 153. Raw Materials Key Suppliers Lists
 Table 154. Montelukast Sodium Downstream Customers
 Table 155. Montelukast Sodium Distributors List
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources


List of Figures
 Figure 1. Montelukast Sodium Product Picture
 Figure 2. Global Montelukast Sodium Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Montelukast Sodium Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Montelukast Sodium Sales Volume (2020-2031) & (Kg)
 Figure 5. Global Montelukast Sodium Sales Price (2020-2031) & (USD/Kg)
 Figure 6. Montelukast Sodium Report Years Considered
 Figure 7. Global Montelukast Sodium Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Montelukast Sodium Players Sales Volume Ranking (2024) & (Kg)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Montelukast Sodium Revenue in 2024
 Figure 10. Montelukast Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Montelukast Sodium Amorphous Picture
 Figure 12. Montelukast Sodium Crystalline Picture
 Figure 13. Global Montelukast Sodium Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Montelukast Sodium Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Montelukast Sodium Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
 Figure 16. Global Montelukast Sodium Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Montelukast Sodium Price by Type (2020-2031) & (USD/Kg)
 Figure 18. Product Picture of Tablets
 Figure 19. Product Picture of Chewable Tablet
 Figure 20. Product Picture of Oral Solution
 Figure 21. Global Montelukast Sodium Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Montelukast Sodium Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Montelukast Sodium Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
 Figure 24. Global Montelukast Sodium Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Montelukast Sodium Price by Application (2020-2031) & (USD/Kg)
 Figure 26. North America Montelukast Sodium Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Montelukast Sodium Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Montelukast Sodium Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Montelukast Sodium Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Montelukast Sodium Sales Volume (%), (2020-2031)
 Figure 38. United States Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Montelukast Sodium Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Montelukast Sodium Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Montelukast Sodium Sales Value by Application (%), 2024 VS 2031
 Figure 59. Montelukast Sodium Industrial Chain
 Figure 60. Montelukast Sodium Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India